phospho p38 mapk (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
97
Structured Review
Cell Signaling Technology Inc
phospho p38 mapk
Phospho P38 Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 7746 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p38/Phospho-p38+MAPK+(Thr180%2FTyr182)+Antibody/pm42864320-240-25-32
Average 97 stars, based on 7746 article reviews
Phospho P38 Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 7746 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p38/Phospho-p38+MAPK+(Thr180%2FTyr182)+Antibody/pm42864320-240-25-32
Average 97 stars, based on 7746 article reviews
phospho p38 mapk - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Control:Article Title: Muscle Loss Driven by Extracellular Signal-Regulated Kinase Suppression via β-Adrenergic Activation in High-Normal Catecholamine Status Article Snippet: Following three additional washes with 1× TBST, protein bands were visualized using enhanced chemiluminescence solution and quantified using the ChemiDoc imaging system (Thermo Fisher, Waltham, MA, USA; iBright CL1500). .. Primary antibodies used included phospho-PKAc (Cell Signaling Technology, Danvers, MA, USA; 5661), PKA (Cell Signaling Technology, 5842), phospho-ERK (Cell Signaling Technology, 4377), ERK (Santa Cruz Biotechnology, sc-94), phospho-AKT (Cell signaling Technology, 9271), AKT (Cell signaling Technology, 4691), Article Title: Targeting the C/EBPβ-PRAME-EZH2 complex modulates the Netrin-4/AKT axis to inhibit renal cancer tumorigenesis and metastasis. Article Snippet: Cancer-testis antigens are considered clinically attractive targets for cancer treatment, but their functions and mechanisms are not well elucidated.. Here, based on comprehensive bioinformatics analyses, we identify PRAME, a nuclear cancer-testis antigen, as a potential regulator of metastasis in clear cell renal cell carcinoma (ccRCC).. Subsequent RNA-Seq and functional studies illustrate that Netrin-4 (NTN4) is a major downstream effector of PRAME, involved in its oncogenic functions. Cell-Signaling:Article Title: MerTK inhibition by UNC569 triggers DNA damage and JNK/p38 MAPK cascade-driven apoptosis in pancreatic cancer. Article Snippet: .. The following primary antibodies were used: p-Rb (8516), p21 (2947), Snail (3879), cleaved caspase3 (9669), PARP (9542), JNK (9252), Article Title: Targeting the C/EBPβ-PRAME-EZH2 complex modulates the Netrin-4/AKT axis to inhibit renal cancer tumorigenesis and metastasis. Article Snippet: Cancer-testis antigens are considered clinically attractive targets for cancer treatment, but their functions and mechanisms are not well elucidated.. Here, based on comprehensive bioinformatics analyses, we identify PRAME, a nuclear cancer-testis antigen, as a potential regulator of metastasis in clear cell renal cell carcinoma (ccRCC).. Subsequent RNA-Seq and functional studies illustrate that Netrin-4 (NTN4) is a major downstream effector of PRAME, involved in its oncogenic functions. other:Article Title: SKA2 promotes gastric cancer progression by regulating glutathione metabolism Article Snippet: Hemagglutination Assay:Article Title: Targeting the C/EBPβ-PRAME-EZH2 complex modulates the Netrin-4/AKT axis to inhibit renal cancer tumorigenesis and metastasis. Article Snippet: Cancer-testis antigens are considered clinically attractive targets for cancer treatment, but their functions and mechanisms are not well elucidated.. Here, based on comprehensive bioinformatics analyses, we identify PRAME, a nuclear cancer-testis antigen, as a potential regulator of metastasis in clear cell renal cell carcinoma (ccRCC).. Subsequent RNA-Seq and functional studies illustrate that Netrin-4 (NTN4) is a major downstream effector of PRAME, involved in its oncogenic functions. |